U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
189481189481Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaCompletedNo Results AvailableLymphomaBiological: oblimersen sodium|Biological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisone|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00070083
189482189482Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the BladderCompletedNo Results AvailableBladder CancerBiological: BCG vaccine|Biological: NY-ESO-1 peptide vaccine|Biological: sargramostimhttps://ClinicalTrials.gov/show/NCT00070070
189483189483Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast CancerCompletedNo Results AvailableStage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast CancerDrug: celecoxib|Procedure: therapeutic conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00070057
189484189484Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to ChemotherapyCompletedNo Results AvailableBreast CancerDrug: edotecarinhttps://ClinicalTrials.gov/show/NCT00070031
189485189485S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaActive, not recruitingHas ResultsLymphomaBiological: rituximab|Drug: Cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisone|Drug: vincristine sulfate|Radiation: radiation therapy|Biological: Yttrium-90 ibritumomab tiuxetan|Biological: Indium-111 ibritumomab tiuxetanhttps://ClinicalTrials.gov/show/NCT00070018
189486189486J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal AdenocarcinomaActive, not recruitingNo Results AvailableColorectal Cancer|Perioperative/Postoperative ComplicationsProcedure: conventional surgery|Procedure: management of therapy complicationshttps://ClinicalTrials.gov/show/NCT00070005
189487189487Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CMLTerminatedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Myelodysplastic SyndromesRadiation: Total Body Irradiation|Drug: Fludarabine|Drug: Campath 1Hhttps://ClinicalTrials.gov/show/NCT00069992
189488189488Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First RelapseActive, not recruitingNo Results AvailableLymphomaBiological: filgrastim|Biological: rituximab|Drug: cisplatin|Drug: cytarabine|Drug: methylprednisolone|Drug: pixantrone dimaleate|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00069966
189489189489Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionActive, not recruitingHas ResultsEsophageal CancerBiological: filgrastim|Biological: pegfilgrastim|Drug: cisplatin|Drug: fluorouracil|Drug: paclitaxel|Procedure: conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00069953
189490189490Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorCompletedNo Results AvailableBrain and Central Nervous System Tumors|Gastrointestinal Stromal Tumor|SarcomaBiological: sargramostim|Biological: telomerase: 540-548 peptide vaccinehttps://ClinicalTrials.gov/show/NCT00069940
189491189491Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and DepressionTerminatedNo Results AvailableDepression|Neurotoxicity|Unspecified Childhood Solid Tumor, Protocol SpecificDrug: Adderall-XR®|Drug: Concerta®https://ClinicalTrials.gov/show/NCT00069927
189492189492Immune Response to Influenza Vaccine in HIV-Infected IndividualsCompletedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00069914
189493189493Phase II CT-2103/Carboplatin in Ovarian CancerCompletedNo Results AvailableOvarian NeoplasmDrug: CT-2103 (poly(L)glutamate-paclitaxel)|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT00069901
189494189494A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following ProstatectomyCompletedNo Results AvailableProstate CancerDrug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00069888
189495189495A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung CancerCompletedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: Gemcitabine|Drug: LY293111|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00069875
189496189496Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-ThalassemiaCompletedNo Results AvailableBeta-ThalassemiaDrug: Deferitrin (GT56-252)|Drug: desferoxamine (DFO)https://ClinicalTrials.gov/show/NCT00069862
189497189497A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's DiseaseTerminatedNo Results AvailableAlzheimer's DiseaseDrug: ABT-089https://ClinicalTrials.gov/show/NCT00069849
189498189498Study Of AVANDAMET With Or Without Insulin In Type II Diabetes Mellitus PatientsCompletedNo Results AvailableDiabetes Mellitus, Type 2|Non-Insulin-Dependent Diabetes MellitusDrug: Rosiglitazone/metforminhttps://ClinicalTrials.gov/show/NCT00069836
189499189499Study of Acid Reflux in AsthmaCompletedHas ResultsAsthma|Lung Diseases|Lung Diseases, ObstructiveDrug: Esomeprazole|Drug: Placebo proton pump inhibitorhttps://ClinicalTrials.gov/show/NCT00069823
189500189500Role of Chronic Kidney Disease in Cardiovascular DiseaseWithdrawnNo Results AvailableCardiovascular Diseases|Heart Diseases|Kidney Failure, Chronichttps://ClinicalTrials.gov/show/NCT00069810
189501189501Epidemiology of Coronary Heart Disease in Men Aged 40 and OverCompletedNo Results AvailableAtherosclerosis|Coronary Arteriosclerosis|Coronary Disease|Heart Diseases|Cardiovascular Diseaseshttps://ClinicalTrials.gov/show/NCT00069797
189502189502The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)CompletedHas ResultsDiabetes Mellitus, Non-Insulin-DependentDrug: insulin glargine (HOE901)|Drug: omega-3 polyunsaturated fatty acids (PUFA)|Drug: placebo|Device: reusable pen device for insulin injectionhttps://ClinicalTrials.gov/show/NCT00069784
189503189503Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's LymphomaCompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: SDX-105https://ClinicalTrials.gov/show/NCT00069758
189504189504Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy RegimenCompletedNo Results AvailableProstate Cancer|Hormone Refractory Prostate CancerDrug: Satraplatin|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00069745
189505189505Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight LossTerminatedNo Results AvailableObesityBehavioral: qigong|Behavioral: acupressure-TAThttps://ClinicalTrials.gov/show/NCT00069732
189506189506Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNo Results AvailableOpen-Angle Glaucoma|Ocular HypertensionDrug: Glaucoma therapyhttps://ClinicalTrials.gov/show/NCT00069719
189507189507Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension PatientsCompletedNo Results AvailableOpen-angle Glaucoma|Ocular HypertensionDrug: AL-12182 0.003% Ophthalmic Solution|Other: AL-12182 Ophthalmic Solution Vehicle|Drug: Latanoprost 0.005% Ophthalmic Solution|Drug: AL-12182 0.01% Ophthalmic Solution|Drug: AL-12182 0.03% Ophthalmic Solutionhttps://ClinicalTrials.gov/show/NCT00069706
189508189508Evaluation of Chronic Orthostatic IntoleranceCompletedNo Results AvailableSyncopehttps://ClinicalTrials.gov/show/NCT00069693
189509189509Genetic Analysis of Gray Platelet SyndromeCompletedNo Results AvailableGenetic Linkage|Myelofibrosishttps://ClinicalTrials.gov/show/NCT00069680
189510189510Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery DiseaseCompletedNo Results AvailableCoronary ArteriosclerosisProcedure: Forearm blood flow study|Procedure: Brachial artery reactivity study|Procedure: Treadmill exercise testhttps://ClinicalTrials.gov/show/NCT00069654

* Görseller ve İçerik tekif hakkına sahip olabilir